FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Laboratories Lansoprazole Delayed-Release Capsules Recall

Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-3…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Apr 6, 2022
Recall ID
D-0737-2022
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Lansoprazole Delayed-Release Capsules starting Mar 23, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0737-2022 on Apr 6, 2022. Reason: Failed Dissolution Specifications; during long term stability testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications; during long term stability testing.

Product description

Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India

Lot numbers, UPCs & expiration codes

Lot # a) C2103093, Exp. 12/2023; b)C2103092, Exp. 12/2023.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0737-2022
Classification
Class II
Status
Terminated
Recall initiated
Mar 23, 2022
FDA report date
Apr 6, 2022
Quantity
8,352 bottles (30-count), 1,368 bottles (90-count)
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0737-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
89871
Address
107 College Rd E
Code information
Lot # a) C2103093, Exp. 12/2023; b)C2103092, Exp. 12/2023.
Postal code
08540-6623
Report date
Apr 6, 2022
Product type
Drugs
Recall number
D-0737-2022
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
8,352 bottles (30-count), 1,368 bottles (90-count)
Termination date
Feb 2, 2024
Reason for recall
Failed Dissolution Specifications; during long term stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 23, 2022
Initial firm notification
Letter
Center classification date
Mar 31, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0737-2022, published Apr 6, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls